WallStreetZenWallStreetZen

NASDAQ: KTRA
Kintara Therapeutics Inc Stock Ownership - Who owns Kintara Therapeutics?

Insider buying vs selling

Have Kintara Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when KTRA insiders and whales buy or sell their stock.

KTRA Shareholders

What type of owners hold Kintara Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Dennis M. Brown10.07%3,929,265$349.70kInsider
William J. Garner6.21%2,425,207$215.84kInsider
Howard K. Fuguet3.20%1,250,000$111.25kInsider
Donald G. Bahouth2.67%1,042,500$92.78kInsider
Raymond L. Vollintine2.60%1,015,500$90.38kInsider
John K. Bell0.94%365,139$32.50kInsider
Anthony Scott Praill0.71%277,273$24.68kInsider
John Liatos0.50%196,750$17.51kInsider
Keith Murphy0.46%181,010$16.11kInsider
Acadian Asset Management LLC0.33%127,777$11.37kInstitution

1 of 3

KTRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KTRA0.62%27.90%
MYMD46.54%53.46%Net Buying
FNCH1.07%98.93%Net Buying
SCPX6.51%23.91%
LIPO5.92%28.26%Net BuyingNet Buying

Kintara Therapeutics Stock Ownership FAQ

Who owns Kintara Therapeutics?

Kintara Therapeutics (NASDAQ: KTRA) is owned by 0.62% institutional shareholders, 27.90% Kintara Therapeutics insiders, and 71.48% retail investors. Dennis M. Brown is the largest individual Kintara Therapeutics shareholder, owning 3.93M shares representing 10.07% of the company. Dennis M. Brown's Kintara Therapeutics shares are currently valued at $408.64k.

If you're new to stock investing, here's how to buy Kintara Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.